These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10636876)

  • 1. Thyroid hormone-independent interaction between the thyroid hormone receptor beta2 amino terminus and coactivators.
    Oberste-Berghaus C; Zanger K; Hashimoto K; Cohen RN; Hollenberg AN; Wondisford FE
    J Biol Chem; 2000 Jan; 275(3):1787-92. PubMed ID: 10636876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A unique role of the beta-2 thyroid hormone receptor isoform in negative regulation by thyroid hormone. Mapping of a novel amino-terminal domain important for ligand-independent activation.
    Langlois MF; Zanger K; Monden T; Safer JD; Hollenberg AN; Wondisford FE
    J Biol Chem; 1997 Oct; 272(40):24927-33. PubMed ID: 9312095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The N-Terminal A/B domain of the thyroid hormone receptor-beta2 isoform influences ligand-dependent recruitment of coactivators to the ligand-binding domain.
    Tian H; Mahajan MA; Wong CT; Habeos I; Samuels HH
    Mol Endocrinol; 2006 Sep; 20(9):2036-51. PubMed ID: 16645037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid hormone response elements differentially modulate the interactions of thyroid hormone receptors with two receptor binding domains in the steroid receptor coactivator-1.
    Takeshita A; Yen PM; Ikeda M; Cardona GR; Liu Y; Koibuchi N; Norwitz ER; Chin WW
    J Biol Chem; 1998 Aug; 273(34):21554-62. PubMed ID: 9705285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus type 1 Tat binding protein-1 is a transcriptional coactivator specific for TR.
    Ishizuka T; Satoh T; Monden T; Shibusawa N; Hashida T; Yamada M; Mori M
    Mol Endocrinol; 2001 Aug; 15(8):1329-43. PubMed ID: 11463857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CBP-dependent and independent enhancing activity of steroid receptor coactivator-1 in thyroid hormone receptor-mediated transactivation.
    Ikeda M; Kawaguchi A; Takeshita A; Chin WW; Endo T; Onaya T
    Mol Cell Endocrinol; 1999 Jan; 147(1-2):103-12. PubMed ID: 10195697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid hormone response element sequence and the recruitment of retinoid X receptors for thyroid hormone responsiveness.
    Wu Y; Xu B; Koenig RJ
    J Biol Chem; 2001 Feb; 276(6):3929-36. PubMed ID: 11084025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The p160 coactivator PAS-B motif stabilizes nuclear receptor binding and contributes to isoform-specific regulation by thyroid hormone receptors.
    Privalsky ML; Lee S; Hahm JB; Young BM; Fong RN; Chan IH
    J Biol Chem; 2009 Jul; 284(29):19554-63. PubMed ID: 19487700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
    Jeyakumar M; Tanen MR; Bagchi MK
    Mol Endocrinol; 1997 Jun; 11(6):755-67. PubMed ID: 9171239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A regulatory role for RIP140 in nuclear receptor activation.
    Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
    Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of ligand-regulated nuclear receptor corepressor and coactivator binding, key interactions determining ligand potency and efficacy for the thyroid hormone receptor.
    Jeyakumar M; Webb P; Baxter JD; Scanlan TS; Katzenellenbogen JA
    Biochemistry; 2008 Jul; 47(28):7465-76. PubMed ID: 18558711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. General receptor for phosphoinositides 1, a novel repressor of thyroid hormone receptor action that prevents deoxyribonucleic acid binding.
    Poirier MB; Hamann G; Domingue ME; Roy M; Bardati T; Langlois MF
    Mol Endocrinol; 2005 Aug; 19(8):1991-2005. PubMed ID: 15878955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylation of nuclear hormone receptor superfamily members: thyroid hormone causes acetylation of its own receptor by a mitogen-activated protein kinase-dependent mechanism.
    Lin HY; Hopkins R; Cao HJ; Tang HY; Alexander C; Davis FB; Davis PJ
    Steroids; 2005; 70(5-7):444-9. PubMed ID: 15862828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex actions of thyroid hormone receptor antagonist NH-3 on gene promoters in different cell lines.
    Shah V; Nguyen P; Nguyen NH; Togashi M; Scanlan TS; Baxter JD; Webb P
    Mol Cell Endocrinol; 2008 Dec; 296(1-2):69-77. PubMed ID: 18930112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two separate NCoR (nuclear receptor corepressor) interaction domains mediate corepressor action on thyroid hormone response elements.
    Cohen RN; Wondisford FE; Hollenberg AN
    Mol Endocrinol; 1998 Oct; 12(10):1567-81. PubMed ID: 9773980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of TRbeta1-N terminus with steroid receptor coactivator-1 (SRC-1) serves a full transcriptional activation function of SRC-1.
    Iwasaki T; Takeshita A; Miyazaki W; Chin WW; Koibuchi N
    Endocrinology; 2006 Mar; 147(3):1452-7. PubMed ID: 16357047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action.
    Shibata H; Spencer TE; OƱate SA; Jenster G; Tsai SY; Tsai MJ; O'Malley BW
    Recent Prog Horm Res; 1997; 52():141-64; discussion 164-5. PubMed ID: 9238851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of expression of thyroid hormone receptor isoforms and coactivators in liver and heart by thyroid hormone.
    Sadow PM; Chassande O; Koo EK; Gauthier K; Samarut J; Xu J; O'Malley BW; Weiss RE
    Mol Cell Endocrinol; 2003 May; 203(1-2):65-75. PubMed ID: 12782404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Titration by estrogen receptor activation function-2 of targets that are downstream from coactivators.
    Lopez GN; Webb P; Shinsako JH; Baxter JD; Greene GL; Kushner PJ
    Mol Endocrinol; 1999 Jun; 13(6):897-909. PubMed ID: 10379889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains.
    Dutertre M; Smith CL
    Mol Endocrinol; 2003 Jul; 17(7):1296-314. PubMed ID: 12714702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.